2020
DOI: 10.1016/j.ejca.2020.06.011
|View full text |Cite
|
Sign up to set email alerts
|

PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
63
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(67 citation statements)
references
References 37 publications
3
63
1
Order By: Relevance
“…However, sustainment should not be entertained within AHS until at least an overall adherence of 75% to 80% is achieved; therefore, more frequent ERAS team meetings are required to review ERAS adherence and outcomes combined with PDSA cycles targeted at problem areas of low adherence. 28 The overall adherence in the ERAS gynecologic oncology cohort was 75%. This was associated with an LOS reduction of 0.6 days overall, with the findings most pronounced in the high-complexity (debulking) group in which a 1.…”
Section: Jama Network Open | Surgerymentioning
confidence: 98%
“…However, sustainment should not be entertained within AHS until at least an overall adherence of 75% to 80% is achieved; therefore, more frequent ERAS team meetings are required to review ERAS adherence and outcomes combined with PDSA cycles targeted at problem areas of low adherence. 28 The overall adherence in the ERAS gynecologic oncology cohort was 75%. This was associated with an LOS reduction of 0.6 days overall, with the findings most pronounced in the high-complexity (debulking) group in which a 1.…”
Section: Jama Network Open | Surgerymentioning
confidence: 98%
“…Moreover, goal directed fluid therapy, recommended in the ERAS protocol, does not define fluid balance. A recent phase III trial demonstrated a reduction in both length of stay and readmissions in favour of the ERAS protocol vs conventional perioperative management in women with advanced ovarian cancer, however there was no difference in postoperative complications [35].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, prehabilitation programs and enhanced recovery after surgery (ERAS) protocols have been shown to improve the complication rate and shorten the hospital stay of gynecological cancer patients ( 41 ). A recent random trial implementing ERAS for high-complexity advanced ovarian cancer surgery suggested that ERAS should be used as a standard practice for all cytoreductive surgeries against peritoneal carcinomatosis ( 42 ). In light to this notion, the effect of ERAS on the nutritional status of these patients needs to explored in the future to better understand the mechanism of this treatment.…”
Section: Discussionmentioning
confidence: 99%